BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, January 9, 2025
See today's BioWorld
Home
» Wuxi Apptec unit adds $80M privately via China's Third Board
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Wuxi Apptec unit adds $80M privately via China's Third Board
July 15, 2015
By
Shannon Ellis
No Comments
SHANGHAI – The Shanghai-based contract research organization/contract manufacturing powerhouse, Wuxi Apptec, is on the move again, this time demonstrating its ability to creatively leverage capital markets to fund expansionary plans.
BioWorld